NewsBenzingaUBS mantiene calificación neutral para LyondellBasell Industries, reduce el precio objetivo a $62 UBS mantiene calificación neutral para LyondellBasell Industries, reduce el precio objetivo a $62 Benzinga 2026.09.25 16:13 (GMT+0) Open on Benzinga Other news What's Going On With Kinros Gold Stock Today? 'JPMorgan Tweaks Data-Sharing Notices in Battle With Fintechs' - Bloomberg Fresenius Medical Care Refines China Strategy With Targeted Product Focus Stock of the Day: Is this the Bottom for MGM Resorts? Why Is GameStop Stock Falling on Friday? Moleculin Biotech Announces Preclinical Data Showing Annamycin Antitumor Activity In Pancreatic Cancer Is Immune-Mediated
Moleculin Biotech Announces Preclinical Data Showing Annamycin Antitumor Activity In Pancreatic Cancer Is Immune-Mediated
